|
市場調査レポート
商品コード
1219658
ラクターゼの世界市場規模、シェア、産業動向分析レポート:用途別(飲食品、医薬品・栄養補助食品)、地域別展望と予測、2022年~2028年Global Lactase Market Size, Share & Industry Trends Analysis Report By Application (Food & Beverages and Pharmaceutical Products & Dietary Supplements), By Regional Outlook and Forecast, 2022 - 2028 |
||||||
ラクターゼの世界市場規模、シェア、産業動向分析レポート:用途別(飲食品、医薬品・栄養補助食品)、地域別展望と予測、2022年~2028年 |
出版日: 2023年01月31日
発行: KBV Research
ページ情報: 英文 238 Pages
納期: 即納可能
|
ラクターゼの世界市場規模は、予測期間中にCAGR6.5%で成長し、2028年には3億5520万米ドルに達すると予測されます。
しかし、最近、一部の人間社会では、乳幼児期以降の乳製品や非ヒト乳の摂取に対する適応として、ラクターゼの持続性が発達していることが分かっています。特にアイルランド人は、ラクターゼの持続性が異常に高いと言われています。一方、地球上のほとんどの人は、乳糖不耐症の程度はさまざまで、ラクターゼ非持続性です。乳糖をグルコースとガラクトースに分解する小腸のラクターゼ酵素の不足が、乳糖不耐症の原因です。
乳糖不耐症は、一次性、二次性、先天性、発達性の4つに大別されます。一次性乳糖不耐症は、加齢とともにラクターゼの量が減少するために発症します。二次性乳糖不耐症の主な原因は、小腸の障害とされています。感染症、炎症性腸疾患、セリアック病、またはその他の病気が、このような損傷の原因である可能性があります。
COVID-19の影響分析
COVID-19の発生は、多くの国で封鎖されたため、サプライチェーンに影響を及ぼしています。また、世界経済や金融市場が不安定なため、化学品中間体の需要も減少しています。したがって、COVID-19の大流行がもたらした制約が、ラクターゼ市場、特に工業施設の閉鎖や閉鎖によってマイナスの影響を及ぼしているのです。パンデミック後の顧客の好みの変化により、ビジネス要件は在庫整理と清算技術に移行し、消費はストップしています。
市場の成長要因
小児および成人における乳糖不耐症の増加
一次性乳糖不耐症は、小腸が完全に形成される前の乳幼児期に発症する一過性の疾患です。二次不耐性を経験する成人は、一般的に小腸の消化器系に問題があります。また、クローン病や胃腸炎などの疾患は、二次性乳糖不耐症を引き起こす可能性があります。米国国立生物工学情報センター(NCBI)によると、世界の人口のほとんどがラクターゼの機能不全の影響を受けやすいとされています。そのため、乳糖を含まない牛乳や乳製品の開発が進み、乳糖不耐症の人が胃腸の問題を回避するのに役立っています。
ラクターゼ抽出と酵素利用のための新鮮なソースを特定するための調査・開発の増加
ラクターゼ酵素は、さまざまなソースから取得されます。酵素を抽出するために、バクテリアや菌類を含む新しい供給源が、現代の研究開発によって求められています。また、酵素を利用することで、飼料や食品の栄養価を高めることができます。また、酵素は化学廃棄物、水の使用、製品別の生産を制限し、人や環境に対する脅威を最小限に抑えます。飲食品分野では複数の製造工程を経る必要があるため、菌類由来のラクターゼ酵素は酸性pHで安定性があります。
市場抑制要因
ビーガン・ダイエットや乳製品を使わない代替食品の人気の高まり
植物性ミルクは脂肪分と糖分を最小限に抑えているため、脂肪をほとんど摂取しない人の代替品としても好まれています。専門家は、子供や牛乳に過敏症や不耐性を持つ人のために、牛乳の代替品としてアーモンドミルクを使用することを勧めています。しかし、菜食主義者の増加に伴い、以前は乳製品を好んでいた消費者にも植物性食品の人気が出てきています。さらに、多くの医師が、糖尿病や高血圧などの疾患を持つ患者を含め、心臓に問題のある患者に植物由来の食事を勧めています。この要因は、予想される期間中の市場拡大を制限する可能性があります。
ソース別の展望
ラクターゼ市場は、供給源に基づいて、酵母、菌類、細菌に分類されます。細菌セグメントは、2021年にラクターゼ市場でかなりの成長率を調達しました。3つの重要な細菌、Bifidobacterium longum、Lactobacillus acidophilus、Enterococcus faecalisは、ラクターゼ遺伝子の起源となるものです。これらは無乳糖製品を作りながら酵素活性を高めており、非病原性です。病原体ではないため、細菌由来のラクターゼ酵素は、ヒトの栄養補給や治療にも利用されています。細菌由来のラクターゼの利用が拡大していることが、同分野の成長の要因となっています。
形態の展望
ラクターゼ市場は形態によって液体と乾燥に分けられます。液体セグメントは、2021年にラクターゼ市場で最大の収益シェアを獲得しました。液体ラクターゼは生物学的および化学的プロセスを迅速化するため、食品や飲食品に最適です。また、ラクターゼ酵素は液状であるため希釈され、用途に応じて低い希釈率で使用できる可能性があります。このように、乳製品をすぐに摂取できる液状ドロップがあることが大きなメリットであり、同分野の拡大要因となっています。
アプリケーションの展望
ラクターゼ市場は、用途別に食品・飲料と医薬品・栄養補助食品に分類されます。食品および飲料セグメントは、2021年にラクターゼ市場で最大の収益シェアを示しました。一部の個人は、小腸でラクターゼ酵素を製造することができません。ラクターゼが欠乏している人は、それがないと牛乳や乳製品に含まれる天然の二糖類を消化することができません。ラクターゼを牛乳に添加すると、牛乳に含まれる天然の乳糖が加水分解され、まろやかな甘さを残しながらも消化されやすくなります。このような酵素の特性により、飲食品分野での利用が拡大し、同分野の成長を後押ししています。
地域別の展望
ラクターゼ市場を地域別に見ると、北米、欧州、アジア太平洋、LAMEAの4地域で分析されています。北米セグメントは、2021年にラクターゼ市場で最大の収益シェアを記録しました。この地域は乳糖不耐症の人口が多いため、北米のラクターゼ市場の成長の可能性を示しています。米国小児科学会(AAP)は、乳糖不耐症の人に牛乳やその他の乳製品を摂取するよう勧めないよう勧告しており、これらの食品はカルシウムなどの必須栄養素を体に与えるからです。
市場参入企業がとっている主な戦略は、製品の上市と買収です。カーディナルマトリックスで提示された分析に基づき、デュポン社がラクターゼ市場の先駆者です。Koninklijke DSM N.V.、Kerry Group PLC、Novozymes A/Sなどの企業は、ラクターゼ市場における主要な革新的企業の一例です。
List of Figures
The Global Lactase Market size is expected to reach $355.2 Million by 2028, rising at a market growth of 6.5% CAGR during the forecast period.
The milk sugar lactose, also present in other dairy products, is broken down into the simple sugars glucose and galactose by the enzyme lactase. The need for lactase is anticipated to rise globally due to factors including expanding lactose-free demand and rising product research & developments in various fields of application like pharmaceutical, nutritional supplements, and baby nutrition. As a member of the galactosidase enzyme family, lactase hydrolyzes the disaccharide lactose into its component monomers of glucose and galactose.
The brush border layer of the developed enterocytes bordering the small intestine's villi is where lactase is primarily found. On chromosome 2, the LCT gene in humans encodes lactase. The ability of the lactase enzyme to continue functioning as an adult and break down lactose in milk is known as lactase persistence. After weaning, the enzyme's activity is significantly decreased in most mammals.
However, lactase persistence has lately developed in some human societies as an adaptation to the ingestion of dairy products and nonhuman milk after infancy. Irish people, in particular, have unusually high levels of lactase persistence. On the other hand, most people on the planet have varied degrees of lactose intolerance and are lactase non-persistent. Lack of the lactase enzyme in the small intestines, which breaks down lactose into glucose and galactose, is the cause of lactose intolerance.
Primary, secondary, congenital, and developmental are the four main categories of lactose intolerance. Primary lactose intolerance develops as people age because their lactase levels decrease. For the most part, the small intestinal damage is considered the main cause of secondary lactose intolerance. An infection, inflammatory bowel disease, celiac disease, or other illnesses may be accountable for such damage.
COVID-19 Impact Analysis
The COVID-19 outbreak has affected the supply chain due to the lockdown in many nations. Additionally, the outbreak decreased demand for chemical intermediates because of the unpredictability of the world economy and financial markets. Therefore, the constraints brought on by the COVID-19 pandemic have negatively impacted the lactase market, especially by the lockdowns and the closure of industrial facilities. Due to post-pandemic client preference changes, business requirements have transitioned to stock organization and liquidation techniques, with consumption at a stop.
Market Growth Factors
Increasing lactose intolerance in children and adults
Primary lactose intolerance is a transient condition that develops in early infants before the small intestine is fully formed. Adults who experience secondary intolerance typically have gastrointestinal problems in the small intestine. In addition, conditions like Crohn's disease or gastroenteritis can cause secondary lactose intolerance. According to the National Center for Biotechnology Information (NCBI), most of the world's population is susceptible to lactase insufficiency. As a result, the development of lactose-free milk and dairy products has increased, aiding those lactose intolerant in avoiding gastrointestinal issues.
Increased investigation and development to identify fresh sources for lactase extraction and enzyme use
The lactase enzyme is obtained from a variety of sources. To extract the enzyme, novel sources, including bacteria and fungi, are sought after by contemporary research and development. Additionally, the nutritional content of feed and food items is increased by applying enzymes. Enzymes also limit chemical waste, water use, and by-product production, posing minimal threats to people and the environment. Given that the food and beverage sector must go through several production processes, lactase enzymes derived from fungal sources have an acidic pH and are stable.
Market Restraining Factors
Increasing popularity of vegan diets and dairy-free alternatives
Due to its minimal fat and sugar content, plant-based milks are also a well-liked replacement for those who consume little to no fat. Experts suggest using almond milk as a workable replacement of milk for children and anyone with milk sensitivities or intolerances. However, as more individuals adopt a vegan lifestyle, plant-based foods are becoming more popular with consumers who previously preferred dairy products. Additionally, many doctors recommend plant-based diets for patients with cardiac problems, including those who also have diabetes, high blood pressure, and other illnesses. This factor can limit market expansion during the anticipated period.
Source Outlook
Based on source, the lactase market is categorized into yeast, fungi, and bacteria. The bacteria segment procured a considerable growth rate in the lactase market in 2021. Three important bacteria, Bifidobacterium longum, Lactobacillus acidophilus, and Enterococcus faecalis, are the origins of the lactase gene. These have increased enzymatic activity while producing lactose-free products and are non-pathogenic. Since they are not pathogens, lactase enzyme derived from bacteria finds use in human nutrition and for therapeutic purposes. The growing use bacteria sourced lactase is responsible for the growth of the segment.
Form Outlook
On the basis of form, the lactase market is divided into liquid and dry. The liquid segment acquired the largest revenue share in the lactase market in 2021. Since liquid lactase quickens biological and chemical processes, it is perfect for food and beverages. In addition, the lactase enzyme is diluted because it is in a liquid form and can potentially be used at lower dilutions, depending on the application. The availability of lactase liquid drops that enable people to consume dairy rather immediately is the main benefit of this form, and as such is accountable for the segment's expansion.
Application Outlook
Based on application, the lactase market is segmented into food & beverages and pharmaceutical products & dietary supplements. The food and beverages segment witnessed the maximum revenue share in the lactase market in 2021. Some individuals are unable to manufacture the lactase enzyme in the small intestines. People with lactase deficiencies cannot digest the natural disaccharide available in milk and milk products without it. When lactase is added to milk, the naturally occurring lactose in the milk is hydrolyzed, leaving it mildly sweet yet digestible. This characteristic of the enzyme broadens its use in the food and beverage sector and thus boosts the segment's growth.
Regional Outlook
On the basis of region, the lactase market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment recorded the maximum revenue share in the lactase market in 2021. The region's large population of lactose intolerant people presents a growth potential for the North American lactase market. The American Academy of Pediatrics (AAP) advises against encouraging persons who have lactose intolerance to consume milk or any other dairy product because these foods give the body essential nutrients like calcium.
The major strategies followed by the market participants are Product Launches and Acquisitions. Based on the Analysis presented in the Cardinal matrix; DuPont de Nemours, Inc. is the forerunner in the Lactase Market. Companies such as Koninklijke DSM N.V., Kerry Group PLC, Novozymes A/S are some of the key innovators in Lactase Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Kerry Group PLC, Koninklijke DSM N.V., DuPont de Nemours, Inc., Novozymes A/S (Novo Holdings A/S), Chr. Hansen Holding A/S, Advanced Enzyme Technologies Limited, Oenon Holdings, Inc., Mitushi Biopharma, Natural Factors, and Amano Enzyme, Inc.
Recent Strategies Deployed in Lactase Market
Acquisitions and Mergers:
Feb-2022: Kerry completed the acquisition of two biotechnology companies, C-LEcta, a biotechnology innovation company, and Enmex which is an enzyme manufacturer. This acquisition would enhance the company's fermentation and enzyme capabilities.
Oct-2021: Royal DSM, completed the acquisition of First Choice Ingredients, a leading supplier of dairy-based savory flavorings. With this acquisition, DSM would strengthen the growth of First Choice Ingredients by delivering their products outside the US to serve the worldwide customer base. Moreover, DSM would integrate First Choice Ingredients' solutions into DSM's offering to deal with taste, texture, and health for Food & Beverage customers.
Nov-2020: Kerry completed the acquisition of Canadian company Bio-K Plus International, a probiotic company with a range of clinically supported probiotic beverage and supplement applications. This acquisition would broaden Kerry's current suite of probiotics.
Jun-2020: Novozymes completed the acquisition of PrecisionBiotics Group Limited, a healthcare company. This acquisition would focus on human health to make growth in Novozymes' business.
Product Launches and Expansions:
Nov-2020: Royal DSM unveiled its new Maxilact® Super lactase enzyme. With this launch, Royal DSM would aim to develop DSM's offering of Maxilact lactases which would allow dairy manufacturers to build clean tasting lactose-free and sugar-reduced dairy.
Nov-2020: Chr. Hansen announced the launch of next-generation Premium cultures YoFlex® Premium and nu-trish® that would produce a healthy high-textured yogurt, reducing the requirement for added ingredients.
Oct-2020: Novozymes and Firmenich, a privately owned perfume and taste company unveiled their mutually developed natural sugar reduction solution TasteGEM SWL, a sugar reduction solution, with Saphera lactase, a lactase enzyme. Combining both TasteGEM SWL with Saphera lactase, this technology would reduce sugar by up to 50% present in yogurt and other dairy products without the usage of sweeteners.
Geographical Expansions:
May-2022: Kerry Group expanded its geographical footprint by opening an advanced taste manufacturing facility in Africa. Based in KwaZulu-Natal, South Africa, this facility would provide aid in producing sustainable nutrition solutions to meet the demands of consumers across the African continent.
Jan-2022: Kerry Group expanded its business to Jeddah, Saudi Arabia, the company's largest plant in the Middle East, North Africa, and Turkey region. This plant would be utilized in the production of sustainable food ingredients to distribute them all over the Middle East.
Partnerships, Collaborations and Agreements:
Feb-2021: Kerry and Pharma Foods International Co. Ltd. (PFI), a functional food ingredient development and sales company signed a partnership that would develop, apply and sell global joint health ingredient technology for functional foods & beverages and dietary supplements to offer it to Kerry's global customers.
Market Segments covered in the Report:
By Application
By Source
By Form
By Geography
Companies Profiled
Unique Offerings from KBV Research